Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

25,104 signal articles · 228 in last 24h · 119,714 total before filter · latest 51m ago
228last 24h
1448last 7d
240● bullish (7d)
156● bearish (7d)
205publishers
AllMacro262Earnings563M&A102Regulatory19Product12Analyst23
✕ clear all filtersticker: NVDASentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Can XRP Hit $500?
24/7 Wall St.59d agoneutral
Can XRP Hit $500?

If you are an investor who spends a lot of time in XRP (CRYPTO:XRP) circles, you must’ve run into a certain price forecast over and over—$500. It’s the price that would turn a small stake into a fortune, and people repeat it so often that it starts to feel like it might actually happen one ... Can XRP Hit $500?

Prediction: Joby Stock Will Trade at This Price in 2028
24/7 Wall St.59d agoneutral
Prediction: Joby Stock Will Trade at This Price in 2028

Joby Aviation (NYSE:JOBY) is graduating from a flight-test story to a revenue story. The Blade acquisition pushed Q4 2025 revenue to $30.84 million, management is guiding $105 million to $115 million for full-year 2026, and a JFK-to-Manhattan eVTOL flight put the brand in front of every commuter in the country. Yet shares sit at $10, ... Prediction: Joby Stock Will Trade at This Price in 2028

Micron Must Do This on June 24, or Its Stock Could Crash
24/7 Wall St.59d agobearish
Micron Must Do This on June 24, or Its Stock Could Crash

The AI boom has created a market where good results are no longer good enough. Investors have rewarded companies tied to artificial intelligence with premium valuations, but they have also become far less forgiving. A strong quarter can still lead to a falling stock price if management fails to convince Wall Street that growth is ... Micron Must Do This on June 24, or Its Stock Could Crash

Meta’s Recent Pullback Creates an Attractive Buying Opportunity
24/7 Wall St.59d agobullish
Meta’s Recent Pullback Creates an Attractive Buying Opportunity

I am opening with the verdict because the gap between where Meta Platforms (NASDAQ:META) trades today and where our model says it should trade is too wide to bury. After a punishing six months for the stock, our 24/7 Wall St. price target for Meta is $837.78, implying 47.61% upside from $567.58. The recommendation is ... Meta’s Recent Pullback Creates an Attractive Buying Opportunity

Own 500 Shares of Pfizer and JNJ and Here’s Your Annual Dividend Income
24/7 Wall St.59d agoneutral
Own 500 Shares of Pfizer and JNJ and Here’s Your Annual Dividend Income

Passive income is the closest thing investors have to financial gravity. It pulls in money whether you are at your desk, on a beach, or asleep, and it lands in your account no matter what the broader market did that week. Earned income depends on showing up. Dividend income depends on a board of directors ... Own 500 Shares of Pfizer and JNJ and Here’s Your Annual Dividend Income

Jeff Bezos Sets His Sights on a $70 Trillion Market. That’s 10X Bigger than the Ecommerce Market Amazon Dominated
24/7 Wall St.59d agoneutral
Jeff Bezos Sets His Sights on a $70 Trillion Market. That’s 10X Bigger than the Ecommerce Market Amazon Dominated

Jeff Bezos built one of the largest fortunes in history by dominating a roughly $7 trillion global ecommerce market. His next act aims at a target an order of magnitude larger. In his first sit-down as a chief executive since leaving Amazon, Bezos told CNBC’s David Faber that his new venture, Prometheus, is going after ... Jeff Bezos Sets His Sights on a $70 Trillion Market. That’s 10X Bigger than the Ecommerce Market Amazon Dominated

Pharma Momentum Fuels Johnson & Johnson’s Path to Double-Digit Upside
24/7 Wall St.59d agoneutral
Pharma Momentum Fuels Johnson & Johnson’s Path to Double-Digit Upside

Our Johnson & Johnson (NYSE:JNJ) 24/7 Wall St. price target lands at $261.72, pointing to 11.28% upside from the current price of $235.18. Our recommendation is buy, and our model carries a 90% confidence level. JNJ has quietly become one of healthcare’s most reliable compounders again, with oncology firing and dividend support intact. Metric Value ... Pharma Momentum Fuels Johnson & Johnson’s Path to Double-Digit Upside

The Greatest Fund Ever? Why Jim Simons’ Medallion Fund Keeps Winning Without Him
24/7 Wall St.59d agoneutral
The Greatest Fund Ever? Why Jim Simons’ Medallion Fund Keeps Winning Without Him

For most investors, Warren Buffett remains the gold standard. Over six decades running Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B), Buffett generated average annual returns of roughly 20%. That may not sound extraordinary until you remember the S&P 500 returned about half that rate over the same period. A dollar invested with Buffett in the 1960s became a fortune. ... The Greatest Fund Ever? Why Jim Simons’ Medallion Fund Keeps Winning Without Him